NHSE will not extend high-profile cancer test pilot

Prostate cancer cells

NHS England has decided not to extend the use of a high-profile emerging cancer screening technology, casting further doubt on its target to improve early detection.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here